The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
X Demographics
Mendeley readers
Attention Score in Context
Title |
Early Clinical Experiences of Esketamine Nasal Spray in the UK in Adults with Treatment-Resistant Major Depressive Disorder: Advisory Panel Recommendations
|
---|---|
Published in |
Neuropsychiatric Disease and Treatment, February 2023
|
DOI | 10.2147/ndt.s388392 |
Pubmed ID | |
Authors |
Allan H Young, Mohamed Abdelghani, Mario F Juruena, Viktoriya L Nikolova, Ramin Nilforooshan |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 14% |
United States | 1 | 14% |
Unknown | 5 | 71% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 57% |
Scientists | 2 | 29% |
Practitioners (doctors, other healthcare professionals) | 1 | 14% |
Mendeley readers
The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 21 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 2 | 10% |
Researcher | 2 | 10% |
Lecturer | 1 | 5% |
Student > Doctoral Student | 1 | 5% |
Other | 1 | 5% |
Other | 4 | 19% |
Unknown | 10 | 48% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 3 | 14% |
Psychology | 2 | 10% |
Unspecified | 1 | 5% |
Agricultural and Biological Sciences | 1 | 5% |
Biochemistry, Genetics and Molecular Biology | 1 | 5% |
Other | 2 | 10% |
Unknown | 11 | 52% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 March 2023.
All research outputs
#15,155,469
of 26,559,802 outputs
Outputs from Neuropsychiatric Disease and Treatment
#1,279
of 3,166 outputs
Outputs of similar age
#192,819
of 492,542 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#15
of 35 outputs
Altmetric has tracked 26,559,802 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,166 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.9. This one has gotten more attention than average, scoring higher than 58% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 492,542 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.